{
    "nctId": "NCT03007381",
    "briefTitle": "Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn",
    "officialTitle": "Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Length of hospital stay postoperatively",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients 18 years of age or older will be offered inclusion if they are scheduled to undergo unilateral or bilateral postmastectomy abdominally based free flap BR postmastectomy, either in a delayed fashion or at the time of initial mastectomy(ies).\n\nExclusion Criteria:\n\n* Patients will be excluded if they meet any of the exclusion criteria: male; revision surgery; a planned pedicled flap reconstruction; any previous diagnosis of chronic renal disease, gastric ulcers, or bleeding disorder; acetaminophen, NSAID or specific ketorolac sensitivity or allergy; pregnancy; or opioid tolerance defined as preoperative opioid use greater than 50 mg.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}